ホーム › 急性骨髄性白血病 › バージニア › Richmond
Richmond、VAにおける急性骨髄性白血病の臨床試験
Richmondとその周辺地域（約30マイル以内）の拠点で、急性骨髄性白血病に関する12件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
被験者募集中観察研究健康なボランティア歓迎
- Bon Secours Richmond Community Hospital, Richmond
- Bon Secours Saint Mary's Hospital, Richmond
- Bon Secours Cancer Institute at Reynolds Crossing, Richmond
- 他3件
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
被験者募集中第3相
- Virginia Commonwealth University - Massey Cancer Center, Richmond
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
被験者募集中第2相
- VCU Massey Comprehensive Cancer Center, Richmond
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
被験者募集中第2相
- VCU Massey Comprehensive Cancer Center, Richmond
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
被験者募集中第2相
- VCU Massey Comprehensive Cancer Center, Richmond
Metronomic Decitabine-Cedazuridine and Venetoclax in R/R AML, HR-MDS, HR/AP MPN
被験者募集中第2相
- Virginia Commonwealth University, Richmond
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
被験者募集中第3相
- VCU Massey Comprehensive Cancer Center, Richmond
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
被験者募集中第1/2相
- VCU Massey Comprehensive Cancer Center, Richmond
Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
被験者募集中第3相
- Children's Hospital of Richmond at Virginia Commonwealth University, Richmond
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
被験者募集中観察研究
- Virginia Commonwealth University, Richmond
Oral Azacitidine in Transplant-Eligible Patients With Acute Myeloid Leukemia (AML) Suffering From Health-Inequality
被験者募集中第4相
- Virginia Commonwealth University, Richmond
Olutasidenib Single Plus Combo Therapy in IDH1mut AML After Induction and Consolidation
被験者募集中第1相
- Virginia Commonwealth University, Richmond
他の都市における急性骨髄性白血病の試験
- Houston, TX85件の研究
- New York City, NY51件の研究
- Boston, MA44件の研究
- Baldwin Park, CA40件の研究
- Seattle, WA40件の研究
- Columbus, OH35件の研究
- Philadelphia, PA34件の研究
- Durham, NC33件の研究
- Atlanta, GA30件の研究
- Tampa, FL29件の研究
- Chicago, IL26件の研究
- Portland, OR25件の研究
Richmondにおける他の研究
- 乳がん26件の研究
- 非小細胞肺癌25件の研究
- 前立腺がん19件の研究
- 心不全16件の研究
- 肺がん14件の研究
- 大腸癌13件の研究
- 心血管疾患13件の研究
- 脂肪肝12件の研究
- 頭頸部扁平上皮癌12件の研究
- 転移性癌12件の研究
- 悪性黒色腫11件の研究
- 肥満症11件の研究
ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。